BSETrident Lifeline LtdMediumNeutral
Announced Fri, 17 Apr · 17:37 IST

We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....

Fund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹249.95
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-1.5-3.5+0.4+0.8+0.2+8.0+0.1-2.0+4.3
Up moveDown movePending
AI summary

Trident Lifeline Ltd informed BSE that its subsidiary, Trident Mediquip Limited (TML), has allotted equity shares through a private placement to other shareholders. As a result of this allotment, Trident Lifeline's holding in TML has been reduced marginally from 59.77% to 59.47%, a dilution of about 0.30%. TML operates in the pharmaceuticals and chemicals industry, with a turnover of Rs. 21.29 crore in FY24-25 (down from Rs. 28.77 crore in FY22-23). The transaction is classified as a related party transaction but is being carried out at arm's length, with promoter group members participating as allottees.

Likely market impact

This is a subsidiary-level event with a minimal dilution (0.30%) in Trident Lifeline's stake. It is unlikely to have a material impact on the listed company's financials or stock price, though it indicates the subsidiary is raising equity capital from existing/promoter shareholders.